CLASS II Drug recall · Reported 5 Sep 2018 · FDA Enforcement Report

Folic Acid injectable, 10 mg/ml Multiple Dose vial recalled

Auro Pharmacies is recalling Folic Acid injectable, 10 mg/ml Multiple Dose vial, distributed nationwide in the US. The recall was initiated on 21 Aug 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 180611/1, Exp 09-Sep-18
Quantity recalled40 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1166-2018
FDA event ID
80890
Recalling firm
Auro Pharmacies, La Habra, CA
Classification
Class II
Status
Terminated
Recall initiated
21 Aug 2018
FDA classified
29 Aug 2018
Reported
5 Sep 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

21 Aug 2018Recall initiated by company
29 Aug 2018Classified by FDA+8 days
5 Sep 2018Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Folic Acid injectable, 10 mg/ml, 30 ml Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

Where it was distributed

Nationwide in USA

Nationwide

Stores named: Walmart

Questions about this recall

Is Folic Acid injectable, 10 mg/ml Multiple Dose vial recalled?

Yes. Auro Pharmacies recalled Folic Acid injectable, 10 mg/ml Multiple Dose vial on 21 Aug 2018. The recall is Class II and its status is Terminated. Recall number D-1166-2018.

Why was it recalled?

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Which lots are affected?

Lot #: 180611/1, Exp 09-Sep-18

Where was it sold?

Nationwide in USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Auro Pharmacies

All 13